BVF Inc’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,108,815
| Closed | -$4.27M | – | 61 |
|
|
2019
Q1 | $4.27M | Buy |
4,108,815
+65,826
| +2% | +$53.6K | 0.48% | 45 |
|
|
2018
Q4 | $3.02M | Hold |
4,042,989
| – | – | 0.39% | 43 |
|
|
2018
Q3 | $8.57M | Sell |
4,042,989
-56,600
| -1% | -$136K | 0.75% | 37 |
|
|
2018
Q2 | $9.47M | Sell |
4,099,589
-153,600
| -4% | -$447K | 0.92% | 30 |
|
|
2018
Q1 | $13.5M | Sell |
4,253,189
-18,100
| -0.4% | -$49.9K | 1.37% | 22 |
|
|
2017
Q4 | $17.5M | Buy |
+4,271,289
| New | +$18.6M | 2.11% | 16 |
|
|
2017
Q3 | – | Sell |
-4,400,289
| Closed | -$17.8M | – | 14 |
|
|
2017
Q2 | $14.7M | Buy |
4,400,289
+2,639,800
| +150% | +$11M | 2.28% | 16 |
|
|
2017
Q1 | $16.2M | Hold |
1,760,489
| – | – | 2.76% | 12 |
|
|
2016
Q4 | $13.6M | Sell |
1,760,489
-51,516
| -3% | -$473K | 2.73% | 11 |
|
|
2016
Q3 | $20.7M | Buy |
1,812,005
+472,669
| +35% | +$5.5M | 3.9% | 10 |
|
|
2016
Q2 | $16.5M | Hold |
1,339,336
| – | – | 3.51% | 11 |
|
|
2016
Q1 | $13.5M | Buy |
1,339,336
+347,903
| +35% | +$4.08M | 3.35% | 12 |
|
|
2015
Q4 | $22.3M | Sell |
991,433
-384,680
| -28% | -$7.88M | 3.81% | 11 |
|
|
2015
Q3 | $22.8M | Buy |
1,376,113
+111,398
| +9% | +$2.23M | 4.61% | 11 |
|
|
2015
Q2 | $28.5M | Sell |
1,264,715
-19,400
| -2% | -$478K | 5.02% | 9 |
|
|
2015
Q1 | $33.1M | Sell |
1,284,115
-90,700
| -7% | -$2.3M | 6.92% | 5 |
|
|
2014
Q4 | $29.9M | Buy |
1,374,815
+86,968
| +7% | +$1.78M | 5.82% | 5 |
|
|
2014
Q3 | $24.4M | Buy |
1,287,847
+462,200
| +56% | +$9.29M | 5.06% | 6 |
|
|
2014
Q2 | $19.2M | Sell |
825,647
-164,131
| -17% | -$4.05M | 3.04% | 10 |
|
|
2014
Q1 | $33.3M | Sell |
989,778
-100,700
| -9% | -$3.39M | 5.16% | 6 |
|
|
2013
Q4 | $32.2M | Buy |
1,090,478
+698,678
| +178% | +$12.8M | 5.63% | 6 |
|
|
2013
Q3 | $6M | Buy |
+391,800
| New | +$7.26M | 1.03% | 19 |
|
BVF Inc's OMED Position: Q2 2019 in Review
BVF Inc sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 4,108,815 shares — an estimated $4.27M sold.
BVF Inc first reported a position in OMED in Q3 2013 and held it in 22 quarters. The position peaked at $33.3M in Q1 2014. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- BVF Inc reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- BVF Inc sold 4,108,815 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $4.27M.
- BVF Inc first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 22 quarters.
- BVF Inc's OncoMed Pharmaceuticals, Inc. position peaked at $33.3M in Q1 2014.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on BVF Inc's 13F filing for Q2 2019, filed 14 Aug 2019.